Rationale and design of the OPTION study: optimal antitachycardia therapy in ICD patients without pacing indications
Background: Implantable cardioverter‐defibrillators (ICDs) represent the treatment of choice
for primary and secondary prevention of sudden cardiac death but ICD therapy is also …
for primary and secondary prevention of sudden cardiac death but ICD therapy is also …
Rationale and design of the OPTION study: optimal antitachycardia therapy in ICD patients without pacing indications
C Kolb, S Tzeis, M Sturmer, D Babuty, JO Schwab… - 2010 - pubmed.ncbi.nlm.nih.gov
Background Implantable cardioverter-defibrillators (ICDs) represent the treatment of choice
for primary and secondary prevention of sudden cardiac death but ICD therapy is also …
for primary and secondary prevention of sudden cardiac death but ICD therapy is also …
Rationale and design of the OPTION study: optimal antitachycardia therapy in ICD patients without pacing indications.
C Kolb, S Tzeis, M Sturmer, D Babuty… - Pacing and Clinical …, 2010 - europepmc.org
Background Implantable cardioverter-defibrillators (ICDs) represent the treatment of choice
for primary and secondary prevention of sudden cardiac death but ICD therapy is also …
for primary and secondary prevention of sudden cardiac death but ICD therapy is also …
Rationale and design of the OPTION study: optimal antitachycardia therapy in ICD patients without pacing indications.
C Kolb, S Tzeis, M Sturmer, D Babuty, JO Schwab… - 2010 - mediatum.ub.tum.de
Implantable cardioverter-defibrillators (ICDs) represent the treatment of choice for primary
and secondary prevention of sudden cardiac death but ICD therapy is also plagued by …
and secondary prevention of sudden cardiac death but ICD therapy is also plagued by …
Rationale and Design of the OPTION Study: Optimal Antitachycardia Therapy in ICD Patients without Pacing Indications.
C KOLB, S TZEIS, M STURMER… - Pacing & Clinical …, 2010 - search.ebscohost.com
Abstract Background: Implantable cardioverter-defibrillators (ICDs) represent the treatment
of choice for primary and secondary prevention of sudden cardiac death but ICD therapy is …
of choice for primary and secondary prevention of sudden cardiac death but ICD therapy is …
[引用][C] Rationale and Design of the OPTION Study: Optimal Antitachycardia Therapy in ICD Patients without Pacing Indications
C KOLB, S TZEIS, M STURMER… - Pacing and clinical …, 2010 - pascal-francis.inist.fr
Rationale and Design of the OPTION Study: Optimal Antitachycardia Therapy in ICD
Patients without Pacing Indications CNRS Inist Pascal-Francis CNRS Pascal and Francis …
Patients without Pacing Indications CNRS Inist Pascal-Francis CNRS Pascal and Francis …
Rationale and Design of the OPTION Study: Optimal Antitachycardia Therapy in ICD Patients without Pacing Indications
C KOLB, S TZEIS, M STURMER, D BABUTY… - Pacing and Clinical …, 2010 - infona.pl
Background: Implantable cardioverter‐defibrillators (ICDs) represent the treatment of choice
for primary and secondary prevention of sudden cardiac death but ICD therapy is also …
for primary and secondary prevention of sudden cardiac death but ICD therapy is also …